Diabetic drugs Flashcards

1
Q

Insulin drugs: mechanism

A

Bind insulin receptor (tyrosine kinase activity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Insulin drugs: clinical use

A

DM types I and II

Life-threatening hyperkalemia and stress-induced hyperglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Insulin drugs: toxicities

A
Hypoglycemia
Hypersensitivity reaction (rare)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Lispro: type

A

Short-acting insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Aspart: type

A

Short-acting insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

NPH: type

A

Medium-acting insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Glargine: type

A

Long-acting insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Detemir: type

A

long-acting insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Sulfonylureas: action

A

Close K channel in beta-cell membrane (cell depolarizes leading to insulin realease)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Sulfonylureas: clinical use

A

Release of endogenous insulin in DM II

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Sulfonylureas: toxicities

A

First gen: disulfiram-like effect

Second gen: hypoglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Tolbutamide: type

A

1st gen sulfonylurea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Chlorpropamide: type

A

1st gen sulfonylurea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Glyburide: type

A

2nd gen sulfonylurea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Glimepride: type

A

2nd gen sulfonylurea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Glipizide: type

A

2nd gen sulfonylurea

17
Q

Metformin: action

A

unknown, possibly decrease gluconeogenesis, increase glycolysis, decrease serum glucose levels.
Overall: insulin sensitizer

18
Q

Metformin: clinical use

A

Oral hypoglycemic

Useful in patients without islet function

19
Q

Metformin: toxicities

A

lactic acidosis (contraindicated in renal failure, do not use with contrast dye)

20
Q

Glitazones/thiazolidinediones: action

A

Increase insulin sensitivity in peripheral tissue

bind PPAR-gamma, upregulate transcription of glucose and lipid metabolism factors (lowers insulin resistance)

21
Q

Glitazones/thiazolidinediones: clinical use

A

Monotherapy in DM II or as augmenter of other drugs

22
Q

Glitazones/thizolidinediones: 4 toxicities

A

Weight gain, edema, hepatotoxicity, CV toxicity

23
Q

alpha-glucosidase inhibitors: action

A

Inhibit intestinal brush-border alpha glucosidases: delays sugar hydrolysis and glucose absorption

24
Q

alpha-glucosidase inhibitors: clinical use

A

Monotherapy DM II or in combination

25
Q

Alphaglucosidase inhibitors: toxicities

A

GI disturbances

26
Q

acarbose: type

A

alpha-glucosidase inhibitor

27
Q

miglitol: type

A

alphaglucosidase inhibitor

28
Q

Pramlintide: action

A

lower glucagon

29
Q

Pramlintide: use

A

DM II

30
Q

Pramlintide: 3 toxicities

A

Hypoglycemia
Nausea
Diarrhea

31
Q

Exenatide: action

A

Increase insulin, decrease glucagon

32
Q

Exenatide: use

A

DM II

33
Q

Exenatide: 3 toxicities

A

Nausea
Vomiting
Pancreatitis